CDTX vs IP · rev $1.3M vs P/E 43, $26.62B cap
Cidara Therapeutics Inc (CDTX) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
International Paper (IP) is a packaging & containers company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
IP does not have a complete income-statement cache yet.
CDTX currently screens at market cap $6.96B. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the CDTX and IP stock pages for the full models.
Not investment advice.